TERMINATEDPhase 1

Pain, Opioids and Pro-Inflammatory Immune Responses

NCT01210066•University of California, Los Angeles

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Pro-inflammatory ActivityImmunologic Activity Alteration

Interventions

Fentanyl

Cold pressor test

+1 more

Locations

1

United States

Locations (1)

UCLA School of Nursing

Los Angeles, California, United States

Key Dates

Start Date

July 1, 2010

Primary Completion Date

May 1, 2012

Completion Date

May 1, 2012

Last Updated

December 29, 2016

Sponsors

Lead Sponsor

University of California, Los Angeles

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 29, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions